The global analgesics market is set to achieve a revenue of USD 91.62 billion in 2024, reflecting a steady increase in its share within the drugs and medication sector. According to recent market forecasts, the industry is expected to grow at a robust Compound Annual Growth Rate (CAGR) of 4.6% over the forecast period, culminating in a projected valuation of approximately USD 143.65 billion by 2034.
The rising prevalence of chronic pain conditions and the continuous advancements in pain management therapies are driving this growth. As the demand for effective pain relief solutions escalates, the analgesics market is witnessing an upward trend, underscoring its expanding role in the pharmaceutical industry.
Market Highlights:
- Current Valuation: The analgesics market is forecasted to generate revenue of US$ 91.62 billion in 2024.
- Future Outlook: The market is anticipated to reach a valuation of about US$ 143.65 billion by 2034.
- Growth Rate: The industry is projected to grow at a CAGR of 4.6% throughout the forecast period.
The continued innovation in analgesic formulations and increased focus on addressing diverse pain management needs are key factors contributing to the market’s promising trajectory. The sector’s growth reflects the ongoing efforts to enhance patient care and develop more effective pain relief options.
Competitive Landscape for Analgesics Market
Key players are focusing on novel and innovative approaches for the development of non-opioid or non-addictive formulations for pain management. Leading companies are strengthening their product portfolio and global footprint through acquisitions.
The strategy of expansion, new product launches, and approvals by key manufacturers is further strengthening their market presence. Besides these, mergers and acquisitions have emerged as key growth strategies adopted by market players.
Recent Developments in the Global Analgesics Market
- ZYNRELEF was launched in July 2021 by Heron Therapeutics Inc., based in the United States. Designed to provide postsurgical analgesia for up to 72 hours after a bunionectomy, inguinal herniorrhaphy, or total knee replacement, it is an extended-release product for soft tissue or periarticular application.
- In October 2017, Pfizer Inc., and other leading healthcare organizations AmerisourceBergen, Blue Cross Blue Shield Association, and Prime Therapeutics joined Walgreens (the United States’ largest drugstore chain) to combat the national opioid abuse crisis by expanding the availability of safe medication disposal kiosks to an additional 900 Walgreens stores.
- In May 2020, Assertio Therapeutics, Inc., based in California, merged with Zyla Life Sciences, based in Pennsylvania. The merger created a growing commercial pharmaceutical company with neurology, inflammation, and pain products.
A Old Full Report Analysis Click Here
Key Segments Covered by Analgesics Industry Survey Report
By Drug Class:
- Opioids
- NSAIDs
- Local Anesthetics
- Acetaminophen
By Indication:
- Surgical Pain
- Cancer Pain
- Neuropathic Pain
By Route of Administration:
- Oral
- Parenteral
- Transdermal
By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Drug Store
- Clinics
- Other Sales Channels
By Region:
- North America
- Latin America
- Europe
- East Asia
- South Asia and Pacific
- Middle East and Africa (MEA)
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
